Robert M Grant, MD, MPH, is Professor of Medicine at the University of California, San Francisco, Chief Medical Officer of the San Francisco AIDS Foundation, Senior Investigator at the Gladstone Institutes, Director of the UCSF Laboratory of Clinical Virology, and a consultant with the World Health Organization. He has 32 years of the experience with HIV/AIDS research and clinical care, including 18 years of research on pre- and post-exposure prophylaxis (PrEP and PEP).
Dr. Grant designed and led the iPrEx trial, which included men and transgender women who have sex with men in Thailand, South Africa, Brazil, Peru, Ecuador, and the United States. The trial showed that oral FTC/TDF PrEP was safe and effective for HIV prevention, and led to approval of PrEP by the U.S. Food and Drug Administration and recommendations from the Centers for Disease Control and Prevention. Currently, Dr. Grant is focused on developing best practices for PrEP implementation. He directs the sexual health clinic at the UCSF Medical Center, oversees the Magnet community sexual health clinic which has more than 600 people on PrEP, and is a co-principal investigator of the CRUSH project that provides PrEP to young people in Oakland, California. He leads the HPTN 067/ADAPT trial that compared daily and non-daily PrEP regimens in Africa, Thailand and the United States.